Exploiting the PI3K/AKT pathway for cancer drug discovery
- PMID: 16341064
- DOI: 10.1038/nrd1902
Exploiting the PI3K/AKT pathway for cancer drug discovery
"VSports" Abstract
Evolving studies with several different targeted therapeutic agents are demonstrating that patients with genomic alterations of the target, including amplification, translocation and mutation, are more likely to respond to the therapy. Recent studies indicate that numerous components of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway are targeted by amplification, mutation and translocation more frequently than any other pathway in cancer patients, with resultant activation of the pathway. This warrants exploiting the PI3K/AKT pathway for cancer drug discovery VSports手机版. .
Publication types
- V体育平台登录 - Actions
- Actions (VSports手机版)
- V体育官网 - Actions
MeSH terms
- Actions (V体育安卓版)
- "V体育安卓版" Actions
- "VSports" Actions
- "V体育安卓版" Actions
- Actions (V体育官网)
- Actions (VSports)
- "VSports手机版" Actions
- Actions (VSports)
Substances
LinkOut - more resources
Full Text Sources
"VSports" Other Literature Sources
Medical
